Fluindione is an oral anticoagulant that belongs to the vitamin K antagonist (VKA) class. It is used to prevent and treat thromboembolic disorders, such as deep vein thrombosis and pulmonary embolism.
Fluindione (Adverse Reactions)
Fluindione (marketed as Previscan®) is an anticoagulant with a half-life of approximately 30 hours, allowing it to remain in the body for an extended period after administration. It is commonly used in France, while other European countries tend to use other anticoagulants, such as acenocoumarol and phenprocoumon. Warfarin is more frequently used in North America, Scandinavia, the United Kingdom, and Asian countries.
Due to its narrow therapeutic range, it is essential to regularly monitor the International Normalized Ratio (INR) to adjust the VKA dose and ensure adequate anticoagulation, thus minimizing the risk of bleeding.
MECHANISM OF ACTION
Its mechanism of action involves the inhibition of the synthesis of vitamin K-dependent coagulation factors in the liver, which reduces the formation of blood clots.
CONTRAINDICATIONS
Fluindione is contraindicated in the following cases:
- Allergy to fluindione or its components.
- Pregnancy and lactation
- Severe hepatic impairment
- Use with other medications containing high doses of aspirin, phenylbutazone, miconazole (except for forms intended for cutaneous application), or St. John's wort.
SIDE EFFECTS
Bleeding is the most common adverse effect of fluindione and can manifest in different parts of the body, from minor bleeding to severe hemorrhages. The appearance of small purple spots on the skin due to microhemorrhages is also possible. Other adverse effects include gastrointestinal problems, hair loss, and hypersensitivity reactions that can affect the skin, liver, and kidneys.
INTERACTIONS
Fluindione can interact with various medications, which can increase or decrease its anticoagulant effect. Therefore, it is essential to inform the doctor about all medications and supplements being taken to prevent adverse interactions. Certain compounds, such as glucosamine used in the treatment of osteoarthritis, may enhance the effect of fluindione; therefore, patients undergoing treatment with both should be carefully monitored.
Like other anticoagulants, fluindione can also interact with certain foods. For example, garlic consumption could intensify its anticoagulant effect. Significant variations in the consumption of foods rich in vitamin K (such as broccoli, carrots, sauerkraut, cabbage, cauliflower, Brussels sprouts, spinach, fennel, liver, lettuce, tomatoes, etc.) also influence the activity of these anticoagulants. Both excessive vitamin K intake and a drastic reduction in intake and prolonged fasting can affect the treatment.
TRADEMARKS
- Previscan®
Genes analyzed
Bibliography
Cullell N, Carrera C, Muiño E, et al. Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants. Oncotarget. 2018 Jun 26;9(49):29238-29258.
Lamoureux F, Duflot T; French Network of Pharmacogenetics (RNPGX). Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx). Therapie. 2017 Apr;72(2):257-267.
